JP2011523637A5 - - Google Patents

Download PDF

Info

Publication number
JP2011523637A5
JP2011523637A5 JP2011508938A JP2011508938A JP2011523637A5 JP 2011523637 A5 JP2011523637 A5 JP 2011523637A5 JP 2011508938 A JP2011508938 A JP 2011508938A JP 2011508938 A JP2011508938 A JP 2011508938A JP 2011523637 A5 JP2011523637 A5 JP 2011523637A5
Authority
JP
Japan
Prior art keywords
vivo imaging
receptor
gaba
imaging method
gene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2011508938A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011523637A (ja
Filing date
Publication date
Priority claimed from GBGB0808832.0A external-priority patent/GB0808832D0/en
Application filed filed Critical
Publication of JP2011523637A publication Critical patent/JP2011523637A/ja
Publication of JP2011523637A5 publication Critical patent/JP2011523637A5/ja
Pending legal-status Critical Current

Links

JP2011508938A 2008-05-15 2009-05-15 うつ病に関するgabaバイオマーカー Pending JP2011523637A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0808832.0A GB0808832D0 (en) 2008-05-15 2008-05-15 Biomarkers for depression
GB0808832.0 2008-05-15
PCT/EP2009/055944 WO2009138500A1 (en) 2008-05-15 2009-05-15 Gaba biomarkers for depression

Publications (2)

Publication Number Publication Date
JP2011523637A JP2011523637A (ja) 2011-08-18
JP2011523637A5 true JP2011523637A5 (https=) 2012-06-28

Family

ID=39571406

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011508938A Pending JP2011523637A (ja) 2008-05-15 2009-05-15 うつ病に関するgabaバイオマーカー

Country Status (6)

Country Link
US (1) US8562950B2 (https=)
EP (1) EP2281067A1 (https=)
JP (1) JP2011523637A (https=)
CN (1) CN102099489A (https=)
GB (1) GB0808832D0 (https=)
WO (1) WO2009138500A1 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0808834D0 (en) * 2008-05-15 2008-06-18 Ge Healthcare Ltd Biomarkers for depression
GB0808833D0 (en) * 2008-05-15 2008-06-18 Ge Healthcare Ltd Biomarkers for depression
US20130046093A1 (en) * 2011-08-18 2013-02-21 Korea Institute Of Science And Technology Pharmaceutical compositions for preventing or treating degenerative brain disease and method of screening the same
AU2013329000A1 (en) * 2012-10-12 2015-04-30 Northwestern University Methods of identifying compounds for treating depression and other related diseases
US20180348195A1 (en) * 2015-11-12 2018-12-06 Kyushu University, National University Corporation Biomarker for diagnosing depression and use of said biomarker
JP7264384B2 (ja) 2019-03-29 2023-04-25 日本たばこ産業株式会社 うつ病の評価を補助するための方法及びうつ病の治療法の効果の評価を補助するための方法、並びにうつ病若しくはうつ病の治療法の効果を評価するためのデータを取得する方法
CN111944835B (zh) * 2019-05-14 2022-03-29 南通大学 一种突变型gabrg2转基因斑马鱼癫痫模型的构建方法及应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999040114A1 (en) 1998-02-05 1999-08-12 Merck & Co., Inc. Novel gabab receptor dna sequences
US7247442B1 (en) * 1998-05-12 2007-07-24 Human Genome Sciences, Inc. Antibodies to HHPEN62 polypeptide
JP2004508359A (ja) 2000-09-06 2004-03-18 ニューロゲン コーポレイション アリール置換テトラヒドロインダゾール、及び、gaba−a受容体に対するリガンドとしてのそれらの使用
WO2004047727A2 (en) * 2002-11-01 2004-06-10 The Board Of Trustees Of The Leland Stanford Junior University Compositions and methods for diagnosing and treating mood disorders
US20050209181A1 (en) * 2003-11-05 2005-09-22 Huda Akil Compositions and methods for diagnosing and treating mental disorders
DK1766077T3 (da) 2004-06-21 2012-07-16 Univ Leland Stanford Junior Differentielt udtrykte gener og veje i bipolar forstyrrelse og/eller alvorlig depressiv forstyrrelse
WO2008020435A2 (en) 2006-08-15 2008-02-21 Quark Pharmaceuticals, Inc Compositions and methods for treatment of mood disorders
GB0808834D0 (en) * 2008-05-15 2008-06-18 Ge Healthcare Ltd Biomarkers for depression
GB0808833D0 (en) * 2008-05-15 2008-06-18 Ge Healthcare Ltd Biomarkers for depression

Similar Documents

Publication Publication Date Title
JP2011523637A5 (https=)
Best et al. New and old TSPO PET radioligands for imaging brain microglial activation in neurodegenerative disease
Meles et al. Circuit imaging biomarkers in preclinical and prodromal Parkinson's disease
Edison et al. In vivo imaging of glial activation in Alzheimer's disease
JP2011523636A5 (https=)
Lotankar et al. Biomarkers for Parkinson’s disease: recent advancement
Cocker et al. Imaging atherosclerosis with hybrid [18F] fluorodeoxyglucose positron emission tomography/computed tomography imaging: what Leonardo da Vinci could not see
Lu et al. PET/SPECT molecular imaging in clinical neuroscience: recent advances in the investigation of CNS diseases
Caroli et al. Cerebral perfusion correlates of conversion to Alzheimer's disease in amnestic mild cognitive impairment
Stoessl Neuroimaging in the early diagnosis of neurodegenerative disease
Seo et al. Technological development and advances in single-photon emission computed tomography/computed tomography
Peever et al. Breakdown in REM sleep circuitry underlies REM sleep behavior disorder
Calabria et al. Current status and future challenges of brain 18 imaging with F-DOPA PET for movement disorders
de la Fuente-Fernández Imaging of dopamine in PD and implications for motor and neuropsychiatric manifestations of PD
Yokokura et al. Alterations in serotonin transporter and body image-related cognition in anorexia nervosa
Zou et al. Position emission tomography/single‐photon emission tomography neuroimaging for detection of premotor Parkinson's disease
JP2011523638A5 (https=)
Bauckneht et al. New tracers and new perspectives for molecular imaging in Lewy body diseases
Borja et al. A critical review of PET tracers used for brain tumor imaging
Llenas-García et al. Primary extragastrointestinal stromal tumors in the omentum and mesentery: a clinicopathological and immunohistochemical study.
Sharma Translational multimodality neuroimaging
Jost et al. Neuroimaging in multiple system atrophy: clinical implications and novel developments
Chiloiro et al. Lights or shadows, a promising future for positron emission tomography in pituitary tumors: a systematic review
JP2008539782A5 (https=)
Hurd et al. Chapter IX Human forebrain dopamine systems: characterization of the normal brain and in relation to psychiatric disorders